Ramaprasad Srinivasan

Ramaprasad Srinivasan

UNVERIFIED PROFILE

Are you Ramaprasad Srinivasan?   Register this Author

Register author
Ramaprasad Srinivasan

Ramaprasad Srinivasan

Publications by authors named "Ramaprasad Srinivasan"

Are you Ramaprasad Srinivasan?   Register this Author

67Publications

910Reads

5Profile Views

Preclinical efficacy of dual mTORC1/2 inhibitor AZD8055 in renal cell carcinoma harboring a TFE3 gene fusion.

BMC Cancer 2019 Sep 13;19(1):917. Epub 2019 Sep 13.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10 - Hatfield CRC, Room 1-5940, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-019-6096-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6743205PMC
September 2019

The Metabolic Basis of Kidney Cancer.

Cancer Discov 2019 Aug 14;9(8):1006-1021. Epub 2019 May 14.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-1354DOI Listing
August 2019

Kidney cancer in 2017: Challenging and refining treatment paradigms.

Nat Rev Urol 2018 Feb 16;15(2):77-78. Epub 2018 Jan 16.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, CRC2-5950, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nrurol.2017.220
Publisher Site
http://dx.doi.org/10.1038/nrurol.2017.220DOI Listing
February 2018

Recommendations for the Management of Rare Kidney Cancers.

Eur Urol 2017 12 16;72(6):974-983. Epub 2017 Jul 16.

Division of Surgical Oncology, Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.06.040DOI Listing
December 2017

Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma.

Genes Chromosomes Cancer 2017 06 31;56(6):484-492. Epub 2017 Mar 31.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22452DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637959PMC
June 2017

Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer.

Urol Oncol 2017 03 30;35(3):114.e9-114.e14. Epub 2016 Nov 30.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.10.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318247PMC
March 2017

Renal cell carcinoma: molecular characterization and evolving treatment paradigms.

Curr Opin Oncol 2017 Mar 1. Epub 2017 Mar 1.

aUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland bSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000364DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581274PMC
March 2017

Therapeutic Strategies for Hereditary Kidney Cancer.

Curr Oncol Rep 2016 08;18(8):50

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Building 10 - Hatfield CRC, Room 1-5940, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-016-0537-6DOI Listing
August 2016

SnapShot: Renal Cell Carcinoma.

Cancer Cell 2016 Apr;29(4):610-610.e1

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2016.03.021DOI Listing
April 2016

Metabolism and oxidative stress response pathways in kidney cancer: a tale of chance and necessity.

Am Soc Clin Oncol Educ Book 2015 :220-5

From the Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute at the National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.220DOI Listing
February 2016

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

Authors:
W Marston Linehan Paul T Spellman Christopher J Ricketts Chad J Creighton Suzanne S Fei Caleb Davis David A Wheeler Bradley A Murray Laura Schmidt Cathy D Vocke Myron Peto Abu Amar M Al Mamun Eve Shinbrot Anurag Sethi Samira Brooks W Kimryn Rathmell Angela N Brooks Katherine A Hoadley A Gordon Robertson Denise Brooks Reanne Bowlby Sara Sadeghi Hui Shen Daniel J Weisenberger Moiz Bootwalla Stephen B Baylin Peter W Laird Andrew D Cherniack Gordon Saksena Scott Haake Jun Li Han Liang Yiling Lu Gordon B Mills Rehan Akbani Mark D M Leiserson Benjamin J Raphael Pavana Anur Donald Bottaro Laurence Albiges Nandita Barnabas Toni K Choueiri Bogdan Czerniak Andrew K Godwin A Ari Hakimi Thai H Ho James Hsieh Michael Ittmann William Y Kim Bhavani Krishnan Maria J Merino Kenna R Mills Shaw Victor E Reuter Ed Reznik Carl S Shelley Brian Shuch Sabina Signoretti Ramaprasad Srinivasan Pheroze Tamboli George Thomas Satish Tickoo Kenneth Burnett Daniel Crain Johanna Gardner Kevin Lau David Mallery Scott Morris Joseph D Paulauskis Robert J Penny Candace Shelton W Troy Shelton Mark Sherman Eric Thompson Peggy Yena Melissa T Avedon Jay Bowen Julie M Gastier-Foster Mark Gerken Kristen M Leraas Tara M Lichtenberg Nilsa C Ramirez Tracie Santos Lisa Wise Erik Zmuda John A Demchok Ina Felau Carolyn M Hutter Margi Sheth Heidi J Sofia Roy Tarnuzzer Zhining Wang Liming Yang Jean C Zenklusen Jiashan Zhang Brenda Ayala Julien Baboud Sudha Chudamani Jia Liu Laxmi Lolla Rashi Naresh Todd Pihl Qiang Sun Yunhu Wan Ye Wu Adrian Ally Miruna Balasundaram Saianand Balu Rameen Beroukhim Tom Bodenheimer Christian Buhay Yaron S N Butterfield Rebecca Carlsen Scott L Carter Hsu Chao Eric Chuah Amanda Clarke Kyle R Covington Mahmoud Dahdouli Ninad Dewal Noreen Dhalla Harsha V Doddapaneni Jennifer A Drummond Stacey B Gabriel Richard A Gibbs Ranabir Guin Walker Hale Alicia Hawes D Neil Hayes Robert A Holt Alan P Hoyle Stuart R Jefferys Steven J M Jones Corbin D Jones Divya Kalra Christie Kovar Lora Lewis Jie Li Yussanne Ma Marco A Marra Michael Mayo Shaowu Meng Matthew Meyerson Piotr A Mieczkowski Richard A Moore Donna Morton Lisle E Mose Andrew J Mungall Donna Muzny Joel S Parker Charles M Perou Jeffrey Roach Jacqueline E Schein Steven E Schumacher Yan Shi Janae V Simons Payal Sipahimalani Tara Skelly Matthew G Soloway Carrie Sougnez Angela Tam Donghui Tan Nina Thiessen Umadevi Veluvolu Min Wang Matthew D Wilkerson Tina Wong Junyuan Wu Liu Xi Jane Zhou Jason Bedford Fengju Chen Yao Fu Mark Gerstein David Haussler Katayoon Kasaian Phillip Lai Shiyun Ling Amie Radenbaugh David Van Den Berg John N Weinstein Jingchun Zhu Monique Albert Iakovina Alexopoulou Jeremiah J Andersen J Todd Auman John Bartlett Sheldon Bastacky Julie Bergsten Michael L Blute Lori Boice Roni J Bollag Jeff Boyd Erik Castle Ying-Bei Chen John C Cheville Erin Curley Benjamin Davies April DeVolk Rajiv Dhir Laura Dike John Eckman Jay Engel Jodi Harr Ronald Hrebinko Mei Huang Lori Huelsenbeck-Dill Mary Iacocca Bruce Jacobs Michael Lobis Jodi K Maranchie Scott McMeekin Jerome Myers Joel Nelson Jeremy Parfitt Anil Parwani Nicholas Petrelli Brenda Rabeno Somak Roy Andrew L Salner Joel Slaton Melissa Stanton R Houston Thompson Leigh Thorne Kelinda Tucker Paul M Weinberger Cynthia Winemiller Leigh Anne Zach Rosemary Zuna

Molecular pathways in renal cell carcinoma: recent advances in genetics and molecular biology.

Curr Opin Oncol 2015 May;27(3):217-23

aUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland bSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-oncology/2015/05000/Molecula
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CCO.0000000000000186DOI Listing
May 2015

New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease.

Clin Cancer Res 2015 Jan;21(1):10-7

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2993DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795462PMC
January 2015

Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.

Nat Rev Urol 2014 Aug 22;11(8):465-75. Epub 2014 Jul 22.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, CRC Room 1-5940, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2014.162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551450PMC
August 2014

Renal cell carcinoma: molecular biology and targeted therapy.

Curr Opin Oncol 2014 May;26(3):321-7

aUrologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland bSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232438PMC
May 2014

Targeted therapies: treating advanced kidney cancer-miles to go before we sleep.

Nat Rev Clin Oncol 2013 Nov 15;10(11):614-5. Epub 2013 Oct 15.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, CRC Room 1W-5940, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2013.183DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174460PMC
November 2013

Non-clear cell renal cancer: disease-based management and opportunities for targeted therapeutic approaches.

Semin Oncol 2013 Aug;40(4):511-20

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2013.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165483PMC
August 2013

Aerobic glycolysis: a novel target in kidney cancer.

Expert Rev Anticancer Ther 2013 Jun;13(6):711-9

Urologic Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/era.13.57DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165485PMC
June 2013

Evolving therapeutic targets in renal cell carcinoma.

Curr Opin Oncol 2013 May;25(3):273-80

Section of Urologic Oncology, The Cancer Institute of New Jersey and UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e32835fc857DOI Listing
May 2013

Renal medullary carcinoma: molecular, immunohistochemistry, and morphologic correlation.

Am J Surg Pathol 2013 Mar;37(3):368-74

Translational Surgical Pathology and Urologic Oncology sections, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3182770406DOI Listing
March 2013

Renal cell carcinoma with metastases to the gallbladder: four cases from the National Cancer Institute (NCI) and review of the literature.

Urol Oncol 2012 Jul-Aug;30(4):476-81. Epub 2011 Feb 1.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2010.04.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145826PMC
November 2012

Intravenous therapies for castration-resistant prostate cancer: toxicities and adverse events.

Urol Oncol 2012 Jul-Aug;30(4 Suppl):S15-9. Epub 2011 Oct 19.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2011.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274605PMC
November 2012

Targeting the mTOR pathway in Chromophobe Kidney Cancer.

J Cancer 2012 2;3:152-7. Epub 2012 Apr 2.

1. Urologic Oncology Branch, National Cancer Institute, 10 Center Drive, CRC, Building 10, Room 1-5940, Bethesda, MD 20892, USA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/jca.4378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3319981PMC
October 2012

Sarcomatoid renal cell carcinoma: a comprehensive review of the biology and current treatment strategies.

Oncologist 2012 10;17(1):46-54. Epub 2012 Jan 10.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive MSC 1107, Building 10, CRC, Room 1-5940, Bethesda, Maryland 20892-1107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2011-0227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267822PMC
June 2012

Targeted therapeutic strategies for the management of renal cell carcinoma.

Curr Opin Oncol 2012 May;24(3):284-90

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e328351c646DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471654PMC
May 2012

Update on targeted therapies for clear cell renal cell carcinoma.

Curr Opin Oncol 2011 May;23(3):283-9

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0b013e32834479c0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488422PMC
May 2011

Impact of genetics on the diagnosis and treatment of renal cancer.

Curr Urol Rep 2011 Feb;12(1):47-55

Department of Health and Human Services, Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11934-010-0156-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164770PMC
February 2011

Editorial comment.

J Urol 2011 Jan 12;185(1):66. Epub 2010 Nov 12.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2010.09.138DOI Listing
January 2011

Targeted therapies for non-clear renal cell carcinoma.

Target Oncol 2010 Jun 3;5(2):119-29. Epub 2010 Aug 3.

Department of Health and Human Services, Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive Bldg 10 Rm 1-5940, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-010-0148-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003336PMC
June 2010

Molecular diagnosis and therapy of kidney cancer.

Annu Rev Med 2010 ;61:329-43

Urologic Oncology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1146/annurev.med.042808.171650DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921612PMC
May 2010

A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.

Blood 2009 Nov 10;114(20):4494-502. Epub 2009 Aug 10.

Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1203, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-05-222786DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777128PMC
November 2009

Hereditary kidney cancer: unique opportunity for disease-based therapy.

Cancer 2009 May;115(10 Suppl):2252-61

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Building 10 CRC, Room 1-5940, Bethesda, MD 20892-1107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24230DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2720093PMC
May 2009

Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.

J Clin Invest 2008 Mar;118(3):1099-109

Hematology Branch and Flow Cytometry Core Facility, National Heart, Lung, and Blood Institute, Surgery Branch, National Cancer Institute, Department of Clinical Pathology, Clinical Center, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI34409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248804PMC
March 2008

Anti-angiogenic therapy in renal cell cancer.

BJU Int 2007 May;99(5 Pt B):1296-300

Urologic Oncology Branch, Center for Cancer Research, Division of Cancer Prevention, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1464-410X.2007.06834.xDOI Listing
May 2007

Antiangiogenic therapy in renal cell carcinoma: from concept to reality.

Nat Clin Pract Urol 2007 Feb;4(2):74-5

Urologic Oncology Branch, National Cancer Institute, Bethesda, MD 20892-1107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpuro0705DOI Listing
February 2007

Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics.

Clin Cancer Res 2007 Jan;13(2 Pt 2):671s-679s

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1870DOI Listing
January 2007

Mechanisms of disease: the role of heat-shock protein 90 in genitourinary malignancy.

Nat Clin Pract Urol 2006 Nov;3(11):590-601

Urologic Oncology Branch, National Cancer Institute, Room 1-5942, Building 10 CRC, 9000 Rockville Pike, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpuro0604DOI Listing
November 2006

Multiple painful cutaneous nodules and renal mass.

J Am Acad Dermatol 2006 Oct;55(4):683-6

Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jaad.2006.06.026DOI Listing
October 2006

High-dose chemotherapy and allogeneic immunotherapy.

Lancet 2005 Jul 23-29;366(9482):273-5

Hematology Branch, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01406736056696
Publisher Site
http://dx.doi.org/10.1016/S0140-6736(05)66963-2DOI Listing
October 2005

Treatment of relapsed blast-phase Philadelphia-chromosome-positive leukaemia after non-myeloablative stem-cell transplantation with donor lymphocytes and imatinib.

Lancet Oncol 2005 Oct;6(10):809-12

Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Building 10, Hatfield CRC, Room 3-5330, 10 Center Drive MSC 1202, Bethesda, MD 20892-1202, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045057039
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(05)70391-0DOI Listing
October 2005

Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival.

Biol Blood Marrow Transplant 2005 Jul;11(7):542-50

Walter Reed Army Medical Center, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2005.04.009DOI Listing
July 2005

Genetic basis of cancer of the kidney: disease-specific approaches to therapy.

Clin Cancer Res 2004 Sep;10(18 Pt 2):6282S-9S

Urologic Oncology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892-1501, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-050013DOI Listing
September 2004

In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation.

Blood 2004 Feb 2;103(4):1383-90. Epub 2003 Oct 2.

Hematology Branch and Flow Cytometry Core Facility, National Heart, Lung, and Blood Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892-1652, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-04-1281DOI Listing
February 2004